# Darunavir and Rilpivirine Interactions With Levonorgestrel Implant

> **NCT03589027** · PHASE2 · UNKNOWN · sponsor: **Makerere University** · enrollment: 60 (estimated)

## Conditions studied

- HIV-1-infection
- Contraception

## Interventions

- **DRUG:** Levonorgestrel two rod sub-dermal implant
- **DRUG:** Rilpivirine
- **DRUG:** Darunavir+Ritonavir

## Key facts

- **NCT ID:** NCT03589027
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-07
- **Primary completion:** 2019-06
- **Final completion:** 2020-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-03-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03589027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03589027, "Darunavir and Rilpivirine Interactions With Levonorgestrel Implant". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03589027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*